Key facts
- This page summarizes Brian Kenneth Roberts's Form 4 filing for Rezolute, Inc. (RZLT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Nov 2025, 17:53.
Brian Kenneth Roberts - 19 Nov 2025 Form 4 Insider Report for Rezolute, Inc. (RZLT)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- RZLT
- Reported as of
- 19 Nov 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Nov 2025, 17:53:46 UTC
- Prior SEC filing
- 26 Jun 2025
- Next SEC filing
- 17 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Kenneth Roberts
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian Kenneth Roberts filed Form 4 for Rezolute, Inc. (RZLT) on 21 Nov 2025.
Change
- Previous filing in this sequence was filed on 26 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001829608
Primary reporting owner
ROBERTS BRIAN KENNETH
- Relationship
- Chief Medical Officer
- Address
- C/O REZOLUTE, INC., 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
- Signature
- /s/ Brian Kenneth Roberts
- Signature date
- 21 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RZLT
transaction
Common Shares
Award
- Transaction value
- $0
- Shares
- +123,000
- Change %
- +78%
- Price
- $0.000000
- Shares after
- 280,352
- Date
- 19 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
RZLT
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,500
- Date
- 19 Nov 2025
- Ownership
- Held in IRA
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RZLT
transaction
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- $0
- Shares
- +72,000
- Change %
- Price
- $0.000000
- Shares after
- 72,000
- Date
- 19 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 72,000
- Exercise price
- $10.16
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents grant of restricted stock units which vest annually over a three-year period with the first RSUs vesting on December 1, 2026.
Footnote F2
The options vest 1/36th monthly beginning on December 19, 2025.